Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Flexion’s Zilretta poised to shakeup knee osteoarthritis marketplace

Flexion Therapeutics recently announced the FDA approval of Zilretta, (triamcinolone acetonide [TA] extended-release injectable suspension) for the treatment of pain associated with moderate-to-severe knee osteoarthritis (OA). This is a segment of the patient population that GlobalData, a leading data and analytics company, expects to significantly drive the value of the market over the next 10 years.
Read more

Meat without animals NPD to hit shelves in 2021

A growing number start-ups are trying to make meat without animals, with a view to addressing concerns about animal welfare and the carbon footprint of meat. However, Chris Lo, Consumer Analyst at GlobalData, a leading data and analytics company, reports that new products will not be ready to hit shelves until 2021.
Read more

How will Australian consumers and their banks benefit from the A$1 billion NPP infrastructure investment? explores GlobalData

The price tag for Australian banks to bring the country’s New Payments Platform (NPP) into operational service this year is estimated to be $785 million (A$ 1 billion). NPP is an instant payments system for Australian consumers, meeting their needs for new digital-age ways of paying for goods and services. Instant payment systems are becoming […]
Read more

Rising overpopulation is likely to hinder food standards around the world

Population continues to rise globally, especially in the UK, exacerbating concerns over food standards. According to the Office for National Statistics (ONS), the UK population is expected to increase by 3.6 million (5.5%) over the next ten years to 2026, with the 70 million mark being surpassed by 2029. This increase is more pronounced in births, rather than deaths; 46% of the growth is projected to result from more births.
Read more

Asia Pacific is the next wealth hotspot, says GlobalData

The value of liquid assets held by the global population will exceed $100tn by the end of 2017, with frontier and emerging economies leading the way in terms of future growth according to GlobalData, a leading data and analytics company. The company’s latest report, The Global Wealth Market in 2017 which analyzes the current dynamics […]
Read more

Non-small cell lung cancer has largest number of clinical trials in Australia and Globally over the last 5 years

A recent analysis of clinical trial activity in Australia by GlobalData, a leading data and analytics company, revealed that 3,199 clinical trials across all diseases and phases took place in the country between January 01, 2012 and December 31, 2016. Non-small cell lung cancer had the largest number of clinical trials overall in Australia, a pattern reflected globally.
Read more
1 … 52 53 54 55 56 … 61